• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压和其他慢性病药物的处方和配药期限:审查国际政策和证据以为澳大利亚的情况提供信息。

Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting.

机构信息

Department of Health, Medicine and Caring Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.

The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.

出版信息

Hypertens Res. 2024 Aug;47(8):2104-2114. doi: 10.1038/s41440-024-01743-2. Epub 2024 Jun 7.

DOI:10.1038/s41440-024-01743-2
PMID:38849500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11298406/
Abstract

The duration of treatment for which a physician may prescribe a medicine, 'prescription duration', is often dispensed at the pharmacy on multiple occasions of shorter time periods, 'dispensing duration'. These durations vary significantly between and within countries. In Australia, the quantity of medication supplied at each dispensing has recently been extended from 30 to 60 days for a selection of medicines used for chronic health conditions, such as diabetes and hypertension. Dispensing durations vary between countries, with 30, 60 or 90 days being the most common-with 90 days aligning with the recommendation of the 2023 Global Report on Hypertension from the World Health Organization. The full impact of shorter vs longer prescription durations on health costs and outcomes is unknown, but current evidence suggests that 90-day dispensing could reduce costs and improve patient convenience and adherence. More rigorous research is needed.

摘要

医生可以开的药的治疗时长,即“处方时长”,通常会在多次较短的时间内在药店配药,即“配药时长”。这些时长在不同国家和同一国家内都有很大差异。在澳大利亚,为了治疗一些慢性疾病,如糖尿病和高血压,最近将每次配药的药物供应量从 30 天延长到 60 天。各国的配药时长不同,最常见的是 30、60 或 90 天,而 90 天与世界卫生组织 2023 年全球高血压报告的建议一致。较短和较长的处方时长对健康成本和结果的全面影响尚不清楚,但现有证据表明,90 天配药可以降低成本,提高患者的便利性和依从性。需要进行更严格的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/11298406/87d0b9dbee78/41440_2024_1743_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/11298406/5563afa24727/41440_2024_1743_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/11298406/87d0b9dbee78/41440_2024_1743_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/11298406/5563afa24727/41440_2024_1743_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/11298406/87d0b9dbee78/41440_2024_1743_Fig2_HTML.jpg

相似文献

1
Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting.高血压和其他慢性病药物的处方和配药期限:审查国际政策和证据以为澳大利亚的情况提供信息。
Hypertens Res. 2024 Aug;47(8):2104-2114. doi: 10.1038/s41440-024-01743-2. Epub 2024 Jun 7.
2
Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK.对临床实践研究数据链(CPRD)进行回顾性多队列分析,以确定在英国初级医疗中,针对常见慢性病开具短期(<60天)或长期(≥60天)处方长度时,药物浪费成本、配药费和开处方者时间的差异。
BMJ Open. 2017 Dec 4;7(12):e019382. doi: 10.1136/bmjopen-2017-019382.
3
Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.医疗保险受益人与共病慢性病患者的药物不依从性:药房配药渠道的影响。
J Manag Care Spec Pharm. 2016 May;22(5):550-60. doi: 10.18553/jmcp.2016.22.5.550.
4
Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.医疗保险受益人群在服用治疗糖尿病、高血压或高胆固醇药物时,配药渠道与用药依从性之间的关联。
J Manag Care Spec Pharm. 2014 Aug;20(8):851-61. doi: 10.18553/jmcp.2014.20.8.851.
5
Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS.在英国国家医疗服务体系中,为患有慢性健康状况的患者开具更短期处方的长期成本和健康后果。
Appl Health Econ Health Policy. 2018 Jun;16(3):317-330. doi: 10.1007/s40258-018-0383-9.
6
Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling.慢性疾病患者开具更长(3 个月)和更短(28 天)持续时间处方的临床效果和成本效益:系统评价和经济建模。
Health Technol Assess. 2017 Dec;21(78):1-128. doi: 10.3310/hta21780.
7
Prescription opioid dispensing in Australian children and adolescents: a national population-based study.澳大利亚儿童和青少年中处方类阿片类药物的发放情况:一项全国性基于人群的研究。
Lancet Child Adolesc Health. 2019 Dec;3(12):881-888. doi: 10.1016/S2352-4642(19)30329-3. Epub 2019 Oct 8.
8
Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.独立封闭式长期护理药房配药成本分析。
J Manag Care Spec Pharm. 2014 Mar;20(3):291-300. doi: 10.18553/jmcp.2014.20.3.291.
9
Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016.2006 年至 2016 年期间澳大利亚老年人群降压药物的配给模式。
J Cardiovasc Pharmacol Ther. 2019 May;24(3):242-250. doi: 10.1177/1074248418812184. Epub 2018 Nov 21.
10
Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.社区药剂师护理质量的决定因素:一项基于人群的队列研究,使用药房管理索赔数据。
BMJ Open. 2017 Sep 21;7(9):e015877. doi: 10.1136/bmjopen-2017-015877.

引用本文的文献

1
Anticholinergic medication use and falls in Australian residential aged care: a retrospective multisite cohort study.澳大利亚老年护理机构中抗胆碱能药物的使用与跌倒:一项回顾性多中心队列研究。
Aging Clin Exp Res. 2025 Aug 27;37(1):257. doi: 10.1007/s40520-025-03147-9.
2
Strategies to maintain health service provision during the COVID-19 pandemic in refugee settings in Jordan and Uganda.约旦和乌干达难民安置点在新冠疫情期间维持医疗服务提供的策略。
PLOS Glob Public Health. 2025 May 8;5(5):e0004484. doi: 10.1371/journal.pgph.0004484. eCollection 2025.
3
Improving Therapeutic Adherence and Reducing Therapeutic Inertia in the Management of People with Cardiometabolic Diseases: A Call-to-Action from the Middle East.

本文引用的文献

1
Hypertension treatment capacity in India by increased workforce, greater task-sharing, and extended prescription period: a modelling study.通过增加劳动力、扩大任务分担和延长处方期限来提高印度高血压治疗能力:一项建模研究
Lancet Reg Health Southeast Asia. 2022 Dec 14;10:100124. doi: 10.1016/j.lansea.2022.100124. eCollection 2023 Mar.
2
Impact of prescription length supply policy on patient medication adherence in Thailand.泰国处方长度供应政策对患者用药依从性的影响。
BMC Health Serv Res. 2023 May 24;23(1):533. doi: 10.1186/s12913-023-09530-4.
3
Drug-dispensing limits within Medicaid during the COVID-19 pandemic.
改善心血管代谢疾病患者管理中的治疗依从性并减少治疗惰性:来自中东的行动呼吁。
Adv Ther. 2025 Mar;42(3):1340-1359. doi: 10.1007/s12325-024-03103-5. Epub 2025 Jan 22.
在 COVID-19 大流行期间,医疗补助计划中的药品配给限制。
J Manag Care Spec Pharm. 2021 Oct;27(10):1489-1493. doi: 10.18553/jmcp.2021.27.10.1489.
4
Does drug dispensing improve the health outcomes of patients attending community pharmacies? A systematic review.药物配发是否能改善在社区药房就诊的患者的健康结果?系统评价。
BMC Health Serv Res. 2021 Aug 2;21(1):764. doi: 10.1186/s12913-021-06770-0.
5
Pharmacist-led interventions to improve medication adherence in older adults: A meta-analysis.药师主导的干预措施以提高老年人的药物依从性:一项荟萃分析。
J Am Geriatr Soc. 2021 Nov;69(11):3301-3311. doi: 10.1111/jgs.17373. Epub 2021 Jul 20.
6
Returning unwanted medicines to pharmacies: prescribing to reduce waste.将不需要的药品返还给药房:通过处方减少浪费。
Aust Prescr. 2018 Jun;41(3):78-81. doi: 10.18773/austprescr.2018.015. Epub 2018 Jun 1.
7
Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS.在英国国家医疗服务体系中,为患有慢性健康状况的患者开具更短期处方的长期成本和健康后果。
Appl Health Econ Health Policy. 2018 Jun;16(3):317-330. doi: 10.1007/s40258-018-0383-9.
8
Impact of issuing longer- versus shorter-duration prescriptions: a systematic review.开具更长时间与更短时间处方的影响:系统评价。
Br J Gen Pract. 2018 Apr;68(669):e286-e292. doi: 10.3399/bjgp18X695501. Epub 2018 Mar 12.
9
Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling.慢性疾病患者开具更长(3 个月)和更短(28 天)持续时间处方的临床效果和成本效益:系统评价和经济建模。
Health Technol Assess. 2017 Dec;21(78):1-128. doi: 10.3310/hta21780.
10
Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK.对临床实践研究数据链(CPRD)进行回顾性多队列分析,以确定在英国初级医疗中,针对常见慢性病开具短期(<60天)或长期(≥60天)处方长度时,药物浪费成本、配药费和开处方者时间的差异。
BMJ Open. 2017 Dec 4;7(12):e019382. doi: 10.1136/bmjopen-2017-019382.